Natalizumab-induced acquired perforating dermatosis.
Fisher RM, Hadley G, Ieremia E, Moswela O, Zaki F, DeLuca GC, McPherson T.
Fisher RM, et al. Among authors: ieremia e.
Clin Exp Dermatol. 2021 Oct;46(7):1373-1375. doi: 10.1111/ced.14699. Epub 2021 Jun 4.
Clin Exp Dermatol. 2021.
PMID: 34086353
No abstract available.